Original news and analysis on international IP policy
A panel of experts on artificial intelligence last week agreed that there are many opportunities for artificial intelligence to encourage a common good and sustainable living. And they set out several ways to get there.
“Artificial intelligence is as a weapon” and we have to deal with it “as we deal with other weapons,” Cindy Smith, director of the United Nations Interregional Crime and Justice Research Institute (UNICRI), said during a panel discussion at an artificial intelligence summit in Geneva this week. The panel discussion focused on preparing a roadmap to ensure that artificial intelligence develops in “a safe, responsible and, an ethical manner” that benefits all the different segments of our society.
Frederick M. Abbott writes: The US Supreme Court has created a new competitive landscape with its decision adopting international exhaustion of patents. For the pharmaceutical sector, we can expect an initial period of uncertainty as the US Food and Drug Administration (FDA) assesses the regulatory framework affected by the decision and as competing stakeholders advance their interests. In an earlier Inside Views contribution, I addressed the principal impact of the decision on the US pharmaceuticals market: downward pricing pressure.[1] This follow-on addresses some of the regulatory and access issues affected by the decision, observing that parallel trade in pharmaceutical products is a long-standing practice, that recently introduced US legislative proposals may shape the regulatory framework in the United States, and concluding with ways that access programs in favor of developing countries are protected.
On 30 May, the US Supreme Court handed down yet another in a long series of rulings that cut back on the rights of patent owners. This time, the high court made it far more difficult for patentees to impose post-sale restrictions on the use or resale of their patented goods. The ruling should boost parallel imports into the US, increase competition throughout the American economy, lower prices for US consumers, and hurt the bottom line of many companies.
For artificial intelligence enthusiasts, the future is bright. Soon intelligent machines will help humankind solve most problems, and according to one speaker at an artificial intelligence summit in Geneva this week, humans will be outsmarted by robots in the foreseeable future, in an artificial intelligence bliss. For others, artificial intelligence is far from delivering a fully positive outcome, and for several United Nations representatives, such as the World Health Organization, the world should not be entrusted to robots just yet.
It is “amazing” what can be done via the internet and the Internet of Things is a “game changer,” a speaker said during the Internet of Things Week currently taking place in Geneva. Ninety percent of the data in the world has been created in the last two years. And the speed of data creation is still increasing, another speaker said.
It has become a tradition at the World Trade Organization committee on intellectual property to have an agenda item on intellectual property and innovation, and next week's meeting is no exception. More noticeable on the agenda of the committee next week is an item on intellectual property and the public interest that addresses compulsory licensing.
The Global Debate on Intellectual Property, Trade and Development: Past, Present and Future
A Conference in Honour of Pedro Roffe
An unusual meeting is taking place at the World Intellectual Property Organization this week, bringing together entrepreneurs in water and sanitation technology and business models with prospective investors, including clean-tech venture capitalists, private equity and corporate investors.
Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
It is not a mystery, cancer has been spreading for decades, in particular in low and-middle income countries, and is not stopping its course in the foreseeable future. Members of the World Health Organization in committee yesterday adopted a resolution to improve prevention, diagnostics, treatment, and palliative care for cancer, in statements stripped of controversy.
What if you get an aggressive form of breast cancer, and the treatment exists but it is too expensive for you to get? You die. Tragic stories and the possibilities to avert them were centre stage at a panel last week on the margin of the ongoing World Health Assembly. Delinking the cost of research and development from the market prices of medicines was urged by speakers on the panel: representatives of cancer patients, civil society, and the Brazilian deputy ambassador.